The Europe In-Vitro Diagnostics Market is expanding as healthcare systems across the region increasingly adopt advanced diagnostic technologies for disease detection, monitoring, screening, and treatment decisions. In-vitro diagnostics (IVD) include a wide range of laboratory tests, instruments, reagents, and diagnostic systems used to analyze biological samples such as blood, urine, and tissue outside the human body.

Growing demand for early disease detection, increasing healthcare expenditure, an aging population, rising prevalence of chronic diseases, and technological advancements in laboratory diagnostics are supporting the development of the European market. The region is also benefiting from the increasing adoption of molecular diagnostics, immunoassays, point-of-care testing, and other advanced diagnostic technologies.

According to Fortune Business Insights, Europe is the second-largest region in the global in-vitro diagnostics market. The Europe In-Vitro Diagnostics Market is projected to record a CAGR of 7.1% during the forecast period. Meanwhile, the global in-vitro diagnostics market is projected to grow from USD 94.67 billion in 2022 to USD 157.02 billion by 2030.

Why is the Europe In-Vitro Diagnostics Market Growing?

The increasing burden of chronic and infectious diseases is one of the major factors driving demand for in-vitro diagnostic products across Europe. Healthcare providers increasingly rely on laboratory and diagnostic testing to identify diseases at an early stage, monitor treatment outcomes, and support personalized healthcare decisions.

IVD products are widely used for:

• Cancer diagnosis
• Infectious disease testing
• Diabetes testing
• Cardiovascular disease diagnosis
• Genetic testing
• Hormone testing
• Blood screening
• Pregnancy testing
• Drug monitoring
• Preventive health screening

Europe's aging population is another important growth factor. Older individuals are more likely to require regular health monitoring and diagnostic testing, increasing demand for laboratory services and diagnostic technologies.

The growing emphasis on preventive healthcare is also encouraging individuals and healthcare providers to conduct regular diagnostic tests. Early identification of health conditions can support timely intervention and improve disease management.

Technological advancements are further transforming the European diagnostic landscape. Manufacturers are developing automated laboratory systems, molecular diagnostic technologies, rapid testing solutions, and digital diagnostic platforms that can improve testing efficiency and accuracy.

Key Market Trends Shaping Industry Growth